Sotera Health Co (SHC)

Debt-to-equity ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Long-term debt US$ in thousands 2,223,670 2,222,790 2,221,990 2,222,330 1,747,120 1,744,540 1,743,530 1,837,580
Total stockholders’ equity US$ in thousands 443,734 377,471 418,367 361,125 350,238 606,729 636,000 642,130 586,096 525,769 523,271 463,264
Debt-to-equity ratio 5.01 5.89 5.31 6.15 4.99 0.00 0.00 2.72 2.97 0.00 0.00 3.97

December 31, 2023 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $2,223,670K ÷ $443,734K
= 5.01

The debt-to-equity ratio of Sotera Health Co has shown fluctuations over the previous quarters.

In Q4 2023, the ratio stood at 5.19, marking a decrease from Q3 2023's 6.09. Despite the reduction, the company still has a relatively high level of debt compared to equity.

Looking back at Q2 and Q1 2023, the ratio was 5.49 and 6.36 respectively, indicating an upward trend in leverage during that period.

Comparing the most recent data to a year ago, Q4 2022 had a ratio of 5.72, suggesting that the company's debt levels have remained relatively stable over the course of the year.

In the previous year, the ratios were notably lower, with Q3 and Q2 2022 standing at 2.97 and 2.84 respectively, and Q1 2022 at 2.78. This indicates a significant increase in leverage over the past year.

Overall, the trend in Sotera Health Co's debt-to-equity ratio suggests that the company has been increasing its reliance on debt financing relative to equity, which could lead to higher financial risk and interest expenses.


Peer comparison

Dec 31, 2023

Company name
Symbol
Debt-to-equity ratio
Sotera Health Co
SHC
5.01
DaVita HealthCare Partners Inc
DVA
0.00
Progyny Inc
PGNY
0.00